Back to Search Start Over

Nasal expression of SARS-CoV-2 entry receptors in newborns.

Authors :
Heinonen S
Helve O
Andersson S
Janér C
Süvari L
Kaskinen A
Source :
Archives of disease in childhood. Fetal and neonatal edition [Arch Dis Child Fetal Neonatal Ed] 2022 Jan; Vol. 107 (1), pp. 95-97. Date of Electronic Publication: 2021 May 14.
Publication Year :
2022

Abstract

Background: SARS-CoV-2 infection is typically mild in children. Lower expression of SARS-CoV-2 entry receptors in the nasal epithelia have been described in children compared with adults. However, data from newborns are lacking. We compared nasal expression of four SARS-CoV-2 entry receptors between term and preterm newborns and adults.<br />Methods: Nasal scrape samples were obtained from 28 newborns (17 term and 11 preterm) and 10 adults. Reverse-transcription quantitative PCR was used to measure mRNA expression of ACE2, transmembrane serine protease 2 (TMPRSS2), neuropilin 1 (NRP1) and neuropilin 2 (NRP2) and insulin-like growth factor 1 receptor (IGF1R).<br />Results: Expression levels of ACE2, TMPRSS2, NRP1 and NRP2 were lower in term and preterm newborns and IGF1R lower in term newborns compared with adults (p<0.05).<br />Conclusions: Both term and preterm newborns, compared with adults, have lower expression of SARS-CoV-2 entry receptors in nasal epithelium.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
1468-2052
Volume :
107
Issue :
1
Database :
MEDLINE
Journal :
Archives of disease in childhood. Fetal and neonatal edition
Publication Type :
Academic Journal
Accession number :
33990387
Full Text :
https://doi.org/10.1136/archdischild-2020-321334